Cargando…

The purification of reduced β2-glycoprotein I showed its native activity in vitro

BACKGROUND: New evidence has shown that reduced β2-glycoprotein I (β2GPI) has anti-oxidative stress and anti-inflammatory activity. However, the details are still poorly understood. This study aims to prepare stable reduced β2GPI with its native bioactivity in vitro. METHODS: Human β2GPI was purifie...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Saijun, Lu, Ming, Zhao, Jiantong, Liu, Shuaihui, Li, Xin, Zhang, Rui, Liu, Hongyan, Yu, Pei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597989/
https://www.ncbi.nlm.nih.gov/pubmed/28903783
http://dx.doi.org/10.1186/s12944-017-0555-x
_version_ 1783263809089044480
author Zhou, Saijun
Lu, Ming
Zhao, Jiantong
Liu, Shuaihui
Li, Xin
Zhang, Rui
Liu, Hongyan
Yu, Pei
author_facet Zhou, Saijun
Lu, Ming
Zhao, Jiantong
Liu, Shuaihui
Li, Xin
Zhang, Rui
Liu, Hongyan
Yu, Pei
author_sort Zhou, Saijun
collection PubMed
description BACKGROUND: New evidence has shown that reduced β2-glycoprotein I (β2GPI) has anti-oxidative stress and anti-inflammatory activity. However, the details are still poorly understood. This study aims to prepare stable reduced β2GPI with its native bioactivity in vitro. METHODS: Human β2GPI was purified from plasma first with perchloric acid precipitation and then purified with a series of chromatography methods including Sephadex G-25 desalting, SP HP, AF-heparin HC-650 M, and Sephacryl S-200. The purified human β2GPI was reduced with thioredoxin-1 (TRX-1) activated by DL-dithiothreitol (DTT). Glutathione (GSH) was selected to block the free thiols in reduced β2GPI. LC/MS was used to verify the location of free thiols. Western blot analysis was used to detect β2GPI immunoreactivity. MTS and flow cytometry were conducted to investigate its biological effect on oxidative-stress-induced death of human umbilical vein endothelial cells (HUVECs). The levels of tumour necrosis factor-alpha (TNF-α),interleukin-6 (IL-6) interleukin-10 (IL-10),interleukin-12P70 (IL-12P70),interferon-gamma (IFN-γ) and monocyte chemoattractant protein −1(MCP-1) in mouse serum were quantified to assess its anti-inflammatory activity in lipopolysaccharide (LPS)-mediated systemic inflammation. RESULTS: We obtained approximately 10 mg β2GPI (purity 98.7%) from 200 ml plasma. The protein yield was 0.05 mg/ml plasma. β2GPI was then reduced by TRX-1/DTT in vitro; the free thiols were detected on Cys288 and Cys326 in domain V of β2GPI. The GSH blockage stabilized the reduced β2GPI in vitro. This reduced β2GPI can be recognized by the anti-β2GPI antibody, can significantly reduce the death of HUVECs after H(2)O(2) treatment and can significantly decrease the levels of TNF-α, IL-6,IFN-γ and MCP-1 in mice upon LPS stimulation. CONCLUSION: Stable reduced β2GPI can be obtained in vitro by TRX-1 deoxidation followed by the blockage of thiols with GSH. This reduced β2GPI maintains the same immunological activity as oxidized β2GPI and has the ability to counter the oxidative stress induced by H(2)O(2) in HUVECs and inflammation in LPS-mediated inflammation in mice.
format Online
Article
Text
id pubmed-5597989
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55979892017-09-18 The purification of reduced β2-glycoprotein I showed its native activity in vitro Zhou, Saijun Lu, Ming Zhao, Jiantong Liu, Shuaihui Li, Xin Zhang, Rui Liu, Hongyan Yu, Pei Lipids Health Dis Research BACKGROUND: New evidence has shown that reduced β2-glycoprotein I (β2GPI) has anti-oxidative stress and anti-inflammatory activity. However, the details are still poorly understood. This study aims to prepare stable reduced β2GPI with its native bioactivity in vitro. METHODS: Human β2GPI was purified from plasma first with perchloric acid precipitation and then purified with a series of chromatography methods including Sephadex G-25 desalting, SP HP, AF-heparin HC-650 M, and Sephacryl S-200. The purified human β2GPI was reduced with thioredoxin-1 (TRX-1) activated by DL-dithiothreitol (DTT). Glutathione (GSH) was selected to block the free thiols in reduced β2GPI. LC/MS was used to verify the location of free thiols. Western blot analysis was used to detect β2GPI immunoreactivity. MTS and flow cytometry were conducted to investigate its biological effect on oxidative-stress-induced death of human umbilical vein endothelial cells (HUVECs). The levels of tumour necrosis factor-alpha (TNF-α),interleukin-6 (IL-6) interleukin-10 (IL-10),interleukin-12P70 (IL-12P70),interferon-gamma (IFN-γ) and monocyte chemoattractant protein −1(MCP-1) in mouse serum were quantified to assess its anti-inflammatory activity in lipopolysaccharide (LPS)-mediated systemic inflammation. RESULTS: We obtained approximately 10 mg β2GPI (purity 98.7%) from 200 ml plasma. The protein yield was 0.05 mg/ml plasma. β2GPI was then reduced by TRX-1/DTT in vitro; the free thiols were detected on Cys288 and Cys326 in domain V of β2GPI. The GSH blockage stabilized the reduced β2GPI in vitro. This reduced β2GPI can be recognized by the anti-β2GPI antibody, can significantly reduce the death of HUVECs after H(2)O(2) treatment and can significantly decrease the levels of TNF-α, IL-6,IFN-γ and MCP-1 in mice upon LPS stimulation. CONCLUSION: Stable reduced β2GPI can be obtained in vitro by TRX-1 deoxidation followed by the blockage of thiols with GSH. This reduced β2GPI maintains the same immunological activity as oxidized β2GPI and has the ability to counter the oxidative stress induced by H(2)O(2) in HUVECs and inflammation in LPS-mediated inflammation in mice. BioMed Central 2017-09-13 /pmc/articles/PMC5597989/ /pubmed/28903783 http://dx.doi.org/10.1186/s12944-017-0555-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zhou, Saijun
Lu, Ming
Zhao, Jiantong
Liu, Shuaihui
Li, Xin
Zhang, Rui
Liu, Hongyan
Yu, Pei
The purification of reduced β2-glycoprotein I showed its native activity in vitro
title The purification of reduced β2-glycoprotein I showed its native activity in vitro
title_full The purification of reduced β2-glycoprotein I showed its native activity in vitro
title_fullStr The purification of reduced β2-glycoprotein I showed its native activity in vitro
title_full_unstemmed The purification of reduced β2-glycoprotein I showed its native activity in vitro
title_short The purification of reduced β2-glycoprotein I showed its native activity in vitro
title_sort purification of reduced β2-glycoprotein i showed its native activity in vitro
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597989/
https://www.ncbi.nlm.nih.gov/pubmed/28903783
http://dx.doi.org/10.1186/s12944-017-0555-x
work_keys_str_mv AT zhousaijun thepurificationofreducedb2glycoproteinishoweditsnativeactivityinvitro
AT luming thepurificationofreducedb2glycoproteinishoweditsnativeactivityinvitro
AT zhaojiantong thepurificationofreducedb2glycoproteinishoweditsnativeactivityinvitro
AT liushuaihui thepurificationofreducedb2glycoproteinishoweditsnativeactivityinvitro
AT lixin thepurificationofreducedb2glycoproteinishoweditsnativeactivityinvitro
AT zhangrui thepurificationofreducedb2glycoproteinishoweditsnativeactivityinvitro
AT liuhongyan thepurificationofreducedb2glycoproteinishoweditsnativeactivityinvitro
AT yupei thepurificationofreducedb2glycoproteinishoweditsnativeactivityinvitro
AT zhousaijun purificationofreducedb2glycoproteinishoweditsnativeactivityinvitro
AT luming purificationofreducedb2glycoproteinishoweditsnativeactivityinvitro
AT zhaojiantong purificationofreducedb2glycoproteinishoweditsnativeactivityinvitro
AT liushuaihui purificationofreducedb2glycoproteinishoweditsnativeactivityinvitro
AT lixin purificationofreducedb2glycoproteinishoweditsnativeactivityinvitro
AT zhangrui purificationofreducedb2glycoproteinishoweditsnativeactivityinvitro
AT liuhongyan purificationofreducedb2glycoproteinishoweditsnativeactivityinvitro
AT yupei purificationofreducedb2glycoproteinishoweditsnativeactivityinvitro